Cognixion begins home study of a brain-computer interface for communication by people with ALS
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
The trial will test whether a non-invasive brain-computer interface can give people with ALS another way to communicate without constant reliance on eye movement.
The CHOICE study, supported by NIH's National Institute on Deafness and Other Communication Disorders, will enroll 30 adults with amyotrophic lateral sclerosis. For 12 weeks at home, participants will use three options: their own eye-tracking tablet, Cognixion's head-worn brain-computer interface with augmented reality glasses, and a touchscreen version. The primary measure is which option a person chooses and how much time they voluntarily spend using it; communication speed and accuracy, usability, workload, and quality of life will also be measured. The system combines brain-signal sensing, eye tracking, contextual SI, and a digital patient profile. The device remains investigational and has no FDA clearance for medical use.
Sources 1